Will Genome Modifications Define Next-Gen AAV Vectors?
UF researcher Arun Srivastava, Ph.D., a gene therapy pioneer, shares his expert perspective on genome-modified AAV vectors, offering insights into how next-generation viral therapies may be shaped by precision genetic engineering.
Atsena Therapeutics Announces Positive Clinical Data From Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Fu & Dixon Work To Achieve Strategic Dominance
UF researchers Dr. Jie Fu and Dr. Warren Dixon have secured $1.3 million in funding from the DEVCOM Army Research Laboratory to develop advanced strategic planning frameworks for complex, uncertain environments, aiming to enhance decision-making capabilities in defense operations.
Oboro Labs and Knowlify Receive ‘Panelists’ Choice’ Awards at GatorPitch
Six University of Florida startups pitched their business plan to more than 100 attendees from Miami’s investor and entrepreneurial community at UF Innovate’s second GatorPitch Miami event on May 8.
XPRIZE UF
UF Innovate | The Hub resident client FNN, in collaboration with UF researchers, advances to the semi-finals of the XPRIZE Wildfire competition with its AI-driven technology aimed at early detection and suppression of wildfires.
Dalir Joins National Effort To Enable 3D Optical Packaging for Next-Gen AI Chips
UF researcher Hamed Dalir, Ph.D., is collaborating on a $5.2 million federally funded project to develop a transformative 3D optical packaging platform that enables scalable, high-bandwidth, energy-efficient chip-to-chip optical communication.
UF Audio Deepfakes Study Could Ultimately Help Hearing-Impaired Detect Fraud
UF researchers found that cochlear implant users are more vulnerable to audio deepfakes, highlighting the need for better detection systems to protect the hearing-impaired from potential fraud.
UF Innovate Awarded Top Entrepreneurship Honors at International Conference
The University of Florida’s start-up incubator, UF Innovate, further solidified its Accelerator program as among the industry’s best after earning top awards at the 2025 International Business Innovation Association’s annual conference in Philadelphia.
Pheronym®’s Nemastim™ Advances Biological Control of Whiteflies in Breakthrough Foliar Application
UF Innovate | Accelerate alum Pheronym®, an ag-biotech company in sustainable pest management, has announced that pheromones increased beneficial nematodes’ performance against whiteflies in a foliar application.
Oragenics, Inc. Announces Approval To Initiate Phase II Concussion Drug Trial in Australia
UF Innovate | Accelerate graduate Oragenics announced that it has received approval from the Human Research Ethics Committee (HREC) in Australia to initiate a Phase II clinical trial evaluating ONP-002 for the treatment of mild traumatic brain injury (mTBI).